fda warns against semaglutide Bullish for compounded #tirzepatide and #semaglutide ?? Comment “article” for the full story! Some people are overdosing on

In patients with type two diabetes, semaglutide GLP-1 reduces blood sugar levels and reduces their risk of major cardiovascular events such as heart attacks and strokes

The combination of diuretic therapy and gastrointestinal fluid losses from Ozempic-related side effects may compound the risk of hypokalaemia

Available from: MacMahon Copas AN, McComish SF, Fletcher JM, Caldwell MA

Ozempic had a well-tolerated profile across the SUSTAIN clinical trial program with the most common adverse events being generally mild to moderate gastrointestinal disorders, which diminished over time

Beyond the Boards: Foundations of Cardiovascular Prevention with Dr

& Flancbaum, L